HARRY MAHOOD: Open Payments
NPI 1255320909 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 20 payments from 8 companies in 2025. Trend: 2023 $270 · 2024 $976 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $152 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: COBENFY, Qelbree, CAPLYTA, REXULTI, INGREZZA, ARISTADA, Auvelity, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
